Dr. Richard Miller, M.D

NPI: 1114122595
Total Payments
$764,696
2024 Payments
$224,266
Companies
11
Transactions
1,071
Medicare Patients
37
Medicare Billing
$4,865

Payment Breakdown by Category

Other$654,494 (85.6%)
Travel$64,577 (8.4%)
Food & Beverage$24,999 (3.3%)
Consulting$20,290 (2.7%)
Education$336.15 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $654,494 287 85.6%
Travel and Lodging $64,577 363 8.4%
Food and Beverage $24,999 412 3.3%
Consulting Fee $20,290 3 2.7%
Education $336.15 6 0.0%

Top Paying Companies

Company Total Records Latest Year
Alkermes, Inc. $361,452 496 $0 (2024)
Janssen Pharmaceuticals, Inc $216,879 315 $0 (2024)
Teva Pharmaceuticals USA, Inc. $165,203 207 $0 (2024)
Otsuka America Pharmaceutical, Inc. $20,562 30 $0 (2024)
ITI, Inc. $259.50 12 $0 (2023)
Janssen Scientific Affairs, LLC $115.16 1 $0 (2018)
E.R. Squibb & Sons, L.L.C. $80.97 3 $0 (2024)
Indivior Inc. $72.48 4 $0 (2024)
Zimmer Biomet Holdings, Inc. $48.84 1 $0 (2018)
Lundbeck LLC $11.81 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $224,266 284 Teva Pharmaceuticals USA, Inc. ($130,623)
2023 $110,331 180 Alkermes, Inc. ($64,178)
2022 $95,946 151 Janssen Pharmaceuticals, Inc ($48,756)
2021 $77,028 97 Alkermes, Inc. ($56,949)
2020 $33,467 40 Alkermes, Inc. ($28,155)
2019 $61,769 93 Alkermes, Inc. ($36,548)
2018 $82,780 116 Alkermes, Inc. ($57,680)
2017 $79,109 110 Alkermes, Inc. ($39,603)

All Payment Transactions

1,071 individual payment records from CMS Open Payments — Page 1 of 43

Date Company Product Nature Form Amount Type
12/11/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $20.10 General
Category: Central Nervous System
12/11/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $0.58 General
Category: Central Nervous System
12/07/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,340.00 General
Category: PSYCHIATRY
12/04/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Travel and Lodging Cash or cash equivalent $217.75 General
Category: Neuroscience
12/04/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Travel and Lodging Cash or cash equivalent $40.00 General
Category: Neuroscience
12/04/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage Cash or cash equivalent $11.80 General
Category: Neuroscience
11/29/2024 Alkermes, Inc. LYBALVI (Drug), LYBALVI, LYBALVI Travel and Lodging In-kind items and services $32.83 General
Category: CNS
11/27/2024 Alkermes, Inc. LYBALVI (Drug), LYBALVI, LYBALVI Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,060.00 General
Category: CNS
11/25/2024 Teva Pharmaceuticals USA, Inc. UZEDY (Drug) Food and Beverage In-kind items and services $17.67 General
Category: Neurology
11/22/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,150.00 General
Category: Neuroscience
11/21/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,700.00 General
Category: Neuroscience
11/21/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Travel and Lodging In-kind items and services $1,260.75 General
Category: Neuroscience
11/21/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Travel and Lodging Cash or cash equivalent $14.07 General
Category: Neuroscience
11/20/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,150.00 General
Category: Neuroscience
11/20/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,742.00 General
Category: PSYCHIATRY
11/20/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Travel and Lodging In-kind items and services $991.43 General
Category: PSYCHIATRY
11/20/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $122.43 General
Category: Neuroscience
11/20/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Travel and Lodging Cash or cash equivalent $26.80 General
Category: PSYCHIATRY
11/20/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Travel and Lodging Cash or cash equivalent $5.00 General
Category: PSYCHIATRY
11/18/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $26.85 General
Category: Neuroscience
11/18/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $22.55 General
Category: Neuroscience
11/16/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,546.00 General
Category: PSYCHIATRY
11/15/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Travel and Lodging In-kind items and services $5.50 General
Category: Neuroscience
11/15/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Travel and Lodging In-kind items and services $5.50 General
Category: Neuroscience
11/14/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,750.00 General
Category: Neuroscience

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 1 37 122 $18,534 $4,865
Total Patients
37
Total Services
122
Medicare Billing
$4,865
Procedure Codes
1

All Medicare Procedures & Services

1 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 37 122 $18,534 $4,865 26.3%

About Dr. Richard Miller, M.D

Dr. Richard Miller, M.D is a Psychiatry healthcare provider based in Cranston, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1114122595.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Miller, M.D has received a total of $764,696 in payments from pharmaceutical and medical device companies, with $224,266 received in 2024. These payments were reported across 1,071 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($654,494).

As a Medicare-enrolled provider, Miller has provided services to 37 Medicare beneficiaries, totaling 122 services with total Medicare billing of $4,865. Data is available for 1 year (2023–2023), covering 1 distinct procedure/service records.

Practice Information

  • Specialty Psychiatry
  • Other Specialties Psychiatry, Psychiatry
  • Location Cranston, RI
  • Active Since 06/18/2007
  • Last Updated 05/29/2025
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1114122595

Products in Payments

  • INVEGA SUSTENNA (Drug) $151,668
  • UZEDY (Drug) $138,758
  • ARISTADA (Drug) $105,297
  • VIVITROL (Drug) $97,382
  • Aristada 441 mg (Drug) $97,283
  • INVEGA TRINZA (Drug) $60,267
  • Vivitrol (Drug) $37,762
  • Austedo XR (Drug) $25,957
  • LYBALVI (Drug) $23,728
  • REXULTI (Drug) $20,503
  • SPRAVATO (Drug) $4,944
  • CAPLYTA (Drug) $259.50
  • PERSERIS (Drug) $72.48
  • COBENFY (Drug) $65.89
  • AUSTEDO (Drug) $64.41
  • 3.1mmD MTX Implants (Device) $48.84
  • ABILIFY ASIMTUFII (Drug) $41.84
  • ABILIFY MAINTENA (Drug) $17.58
  • BRINTELLIX (Drug) $11.81
  • IMBRUVICA (Drug) $11.36

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Cranston